On October 2, 2019, we registered the issuance of 6,350,000 shares of Common Stock, par value $0.01 per share (“Common Stock”), consisting of 5,300,000 shares of Common Stock reserved for issuance upon the exercise of options granted, or in respect of awards granted, under the Cerence 2019 Equity Incentive Plan, (“Equity Incentive Plan”), and 1,050,000 shares of Common Stock that are reserved for issuance under the Cerence 2019 Employee Stock Purchase Plan. The Equity Incentive Plan provides for the grant of incentive stock options, stock awards, stock units, stock appreciation rights, and certain other stock-based awards. The shares available for issuance will automatically increase on January 1st of each year, by the lesser of (A) three percent (3%) of the number of shares of Common Stock outstanding as of the close of business on the immediately preceding December 31st; and (B) the number of shares of Common Stock determined by the Board on or prior to such date for such year.

Information with respect to our non-vested restricted stock units for the three months ended December 31, 2021 was as follows:

	Non-Vested Restricted Stock Units
	Time-Based Shares			Performance- Based Shares			Total Shares			Weighted- Average Grant-Date Fair Value		Weighted- Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (in thousands)
Non-vested at September 30, 2021		1,420,532			654,619			2,075,151		$	44.20
Granted		364,118			171,583			535,701		$	83.90
Vested		(806,660	)		(474,681	)		(1,281,341	)	$	59.84
Forfeited		(39,647	)		(75,308	)		(114,955	)	$	54.95
Non-vested at December 31, 2021		938,343			276,213			1,214,556		$	64.14
Expected to vest								1,214,556		$	64.14		1.21	$	93,071

Stock-based compensation was included in the following captions in our Condensed Consolidated Statements of Operations for the three months ended December 31, 2021 and 2020 (in thousands):

	Three Months Ended December 31,
	2021			2020
Cost of connected services	$	146		$	291
Cost of professional services		946			1,301
Research and development		1,995			4,138
Sales and marketing		(578	)		2,639
General and administrative		(668	)		4,956
Restructuring and other costs, net		4,000			—
	$	5,841		$	13,325

For the three months ended December 31, 2021, we decreased stock-based compensation expense relating to our performance-based restricted stock units. Compensation cost for our performance-based restricted stock units is recognized based on the number of units expected to vest upon the achievement of the performance conditions. We recorded $4.0 million, net of $5.0 million in forfeitures, in stock-based compensation due to the resignation of our former CEO and the resulting modification of certain stock-based awards in Restructuring and other costs, net.